From the Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
ASAIO J. 2020 Jun;66(6):607-609. doi: 10.1097/MAT.0000000000001178.
The novel coronavirus severe acute respiratory syndrome coronavirus 2 is infecting hundreds of thousands of humans around the globe. The coronavirus disease 2019 (COVID-19) is known to generate mild as well as critical courses. Complications on the intensive care units include acute respiratory distress syndrome, acute cardiac, and kidney injury as well as shock. Here, we present the first case report of a successful treatment of a COVID-19 patient presenting with adult respiratory distress syndrome plus refractory combined cardiogenic and vasoplegic shock, which could be successfully stabilized after implantation of a percutaneous ventricular assist device plus an extracorporeal membrane oxygenation. Although such intense treatment might not be feasible in case of a health care disaster as described for the hot spots of the COVID-19 pandemic, it might encourage treatment of younger patients on intensive care units not overcrowded by critically ill patients.
新型冠状病毒严重急性呼吸综合征冠状病毒 2 正在感染全球数十万人。据了解，冠状病毒病 2019（COVID-19）可导致轻症和重症。重症监护病房的并发症包括急性呼吸窘迫综合征、急性心脏和肾脏损伤以及休克。在这里，我们报告了首例 COVID-19 患者成功治疗的病例，该患者患有成人呼吸窘迫综合征合并难治性心源性和血管扩张性休克，在植入经皮心室辅助装置和体外膜氧合后成功稳定。尽管在 COVID-19 大流行热点地区描述的医疗灾难情况下，这种强化治疗可能不可行，但它可能会鼓励在重症监护病房中治疗没有挤满重症患者的年轻患者。
